Food allergy drug safety trial ends early

NCT ID NCT05678959

Terminated Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at the long-term safety of ligelizumab, an injectable drug, in 163 people with food allergies who had already completed earlier Phase III studies. Participants received either 120 mg or 240 mg of ligelizumab every 4 weeks. The study was terminated, so full results are not available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ligelizumab (an injectable drug)
What this could lead to: If successful, this could show that ligelizumab is safe for long-term use and may help control food allergies.
What could go wrong: The study was terminated early, so results are limited. It is an extension study, not a new treatment test, and long-term safety is still uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

food allergy Peanut Hypersensitivity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FOOD ALLERGY

Contacts and locations

Locations

Allergy and Asthma Associates of Santa Clara Vally Center

San Jose, California, 95117, United States
Allergy and Asthma Clin Res Inc

Walnut Creek, California, 94598, United States
Allergy and Immunology Associates

Scottsdale, Arizona, 85251, United States
Allervie Clinical Research

Birmingham, Alabama, 35209, United States
Ann and Robert H Lurie Childs Hosp

Chicago, Illinois, 60611, United States
Arkansas Children's Hospital

Little Rock, Arkansas, 72202, United States
Asthma and Allergy Associates P C

Colorado Springs, Colorado, 80907, United States
Atlanta Allergy and Asthma Clinic

Marietta, Georgia, 30062, United States
Boston Childrens Hospital

Boston, Massachusetts, 02215, United States
Childrens Healthcare of Atlanta

Atlanta, Georgia, 30342, United States
Childrens Hospital Of Philadelphia

Philadelphia, Pennsylvania, 19104, United States
Cincinnati Childrens Hospital MC

Cincinnati, Ohio, 45229-3039, United States
Family Allergy and Asthma

Lousiville, Kentucky, 40217, United States
Johns Hopkins Childrens Center

Baltimore, Maryland, 21287, United States
Mt Sinai Medical Center

New York, New York, 10029-6574, United States
Northwell Health

New York, New York, 10028, United States
Novartis Investigative Site

Brisbane, Queensland, 4101, Australia
Novartis Investigative Site

Parkville, Victoria, 3052, Australia
Novartis Investigative Site

Nedlands, Western Australia, 6009, Australia
Novartis Investigative Site

Hamilton, Ontario, L8N 3Z5, Canada
Novartis Investigative Site

Ottawa, Ontario, K1Y 4G2, Canada
Novartis Investigative Site

Toronto, Ontario, M3B 3S6, Canada
Novartis Investigative Site

Montreal, Quebec, H3T 1C5, Canada
Novartis Investigative Site

Québec, Quebec, G1V 4W2, Canada
Novartis Investigative Site

Angers, France, 49933, France
Novartis Investigative Site

Lille, 59000, France
Novartis Investigative Site

Toulouse, 31400, France
Novartis Investigative Site

Vandœuvre-lès-Nancy, 54511, France
Novartis Investigative Site

Frankfurt am Main, Hesse, 60590, Germany
Novartis Investigative Site

Frankfurt am Main, Hesse, 60596, Germany
Novartis Investigative Site

Dresden, Saxony, 01307, Germany
Novartis Investigative Site

Berlin, 13353, Germany
Novartis Investigative Site

Padova, PD, 35128, Italy
Novartis Investigative Site

Sagamihara, Kanagawa, 252-0392, Japan
Novartis Investigative Site

Setagaya-ku, Tokyo, 157-8535, Japan
Novartis Investigative Site

Utrecht, 3584 CX, Netherlands
Novartis Investigative Site

Esplugues, Barcelona, 08950, Spain
Novartis Investigative Site

Barcelona, 08036, Spain
Novartis Investigative Site

Madrid, 28009, Spain
Novartis Investigative Site

Madrid, 28040, Spain
Respiratory Medicine Research Institute of Michigan

Ypsilanti, Michigan, 48197, United States
Seattle Allergy and Asthma Rsch

Seattle, Washington, 98115, United States
Texas Childrens Hospital

Houston, Texas, 77030, United States
UBMD Pediatrics

Buffalo, New York, 14203, United States
UCHealth Outpatient Pavilion

Aurora, Colorado, 80045, United States
Univ of South Florida Asthma Allergy and Immunology CRU

Tampa, Florida, 33613, United States
University Of NC At Chapel Hill

Chapel Hill, North Carolina, 27599 9500, United States
University of Michigan Clinical Trials Office

Ann Arbor, Michigan, 48109, United States
Unv of TX Southwestern Medical Center

Dallas, Texas, 75235, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.